<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of glaucoma in infants and children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of glaucoma in infants and children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of glaucoma in infants and children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James D Reynolds, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew L Reynolds, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Evelyn A Paysse, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 09, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Glaucoma is a heterogeneous group of eye diseases that are characterized by a progressive optic neuropathy, manifested by cupping of the optic disc  (<a class="graphic graphic_picture graphicRef71467" href="/z/d/graphic/71467.html" rel="external">picture 1</a>) and usually, but not always, associated with increased intraocular pressure (IOP). Glaucoma can lead to optic nerve damage and consequent visual loss. Peripheral vision loss occurs first, but if glaucoma is untreated, central vision loss and complete blindness can occur [<a href="#rid1">1</a>]. In infants and toddlers, additional damage to the visual system, including large and potentially asymmetric refractive error, corneal edema or scarring, astigmatism, strabismus, and amblyopia, may occur. Early diagnosis and referral are crucial to ensuring optimal visual outcome.</p><p>An overview of the causes, presentation, and treatment of pediatric glaucoma will be presented here. Primary infantile glaucoma and glaucoma in adults are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma"</a> and  <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/6903.html" rel="external">"Angle-closure glaucoma"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>The angle of the eye is the recess formed by the iridocorneal juncture. The scleral spur, trabecular meshwork, and Schwalbe's line lie within this angle. The trabecular meshwork is a fenestrated structure that transmits aqueous fluid to Schlemm's canal, from which it drains into the venous system  (<a class="graphic graphic_figure graphicRef71234" href="/z/d/graphic/71234.html" rel="external">figure 1A</a>). When the drainage of aqueous fluid from the anterior chamber is compromised, a new steady state develops with abnormally high intraocular pressure (IOP)  (<a class="graphic graphic_figure graphicRef71433" href="/z/d/graphic/71433.html" rel="external">figure 2</a>).</p><p class="headingAnchor" id="H3"><span class="h1">CLASSIFICATION</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Open-angle versus angle-closure glaucoma</strong> – Glaucoma can occur as open-angle or angle-closure forms. Each form may present in childhood, and each form may be either acute or chronic.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Open-angle glaucoma</strong> – Open-angle glaucoma is an optic neuropathy characterized by progressive peripheral visual field loss followed by central field loss in a typical pattern. It is usually but not always in the presence of elevated intraocular pressure (IOP). This is the most common form of glaucoma in both for children and adults. (See  <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent2">Open-angle glaucoma implies that the pathway to the angle structures and trabecular meshwork are "open," meaning the obstruction to aqueous outflow is at the level of the trabecular meshwork or distal. When viewed directly via gonioscopy, the trabecular meshwork is visible without evidence of obstruction.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Angle-closure glaucoma</strong> – Angle-closure glaucoma is characterized by narrowing or closure of the anterior chamber angle. Although a myriad of mechanisms of closure are possible, most involve rotational closure from the iris  (<a class="graphic graphic_figure graphicRef71234 graphicRef59454" href="/z/d/graphic/71234.html" rel="external">figure 1A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/6903.html" rel="external">"Angle-closure glaucoma", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent2">In angle-closure glaucoma, the path to the trabecular meshwork is blocked, usually by the iris, but sometimes by neovascularization. When viewed directly by gonioscopy, the angle structures and trabecular meshwork are obscured.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary versus secondary</strong> – Both open-angle and angle-closure glaucoma can be classified into primary and secondary types to provide a framework for the evaluation and management of individual patients  (<a class="graphic graphic_table graphicRef56982" href="/z/d/graphic/56982.html" rel="external">table 1</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Primary glaucoma</strong> – Primary glaucomas are those with isolated angle malformations (trabeculodysgenesis) [<a href="#rid2">2</a>]. Primary glaucoma may have onset at birth, in the first few years of life, or later in life (congenital, primary infantile, and juvenile glaucoma, respectively). The age at which symptoms first appear probably is related to the severity of angle dysgenesis. Although congenital, infantile, and juvenile glaucoma appear to represent three points on the spectrum of one disease, juvenile glaucoma traditionally is treated as a separate entity because it has a different clinical presentation and one that is more similar to primary open-angle glaucoma in adults. (See <a class="local">'Primary glaucoma'</a> below and  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Secondary glaucoma</strong> – Secondary glaucoma either is acquired or related to an underlying ocular abnormality; it can occur at any age and may be present at birth. (See <a class="local">'Secondary glaucoma'</a> below.)</p><p></p><p class="headingAnchor" id="H456851701"><span class="h1">PRIMARY GLAUCOMA</span></p><p class="headingAnchor" id="H4"><span class="h2">Primary infantile glaucoma</span><span class="headingEndMark"> — </span>Primary infantile glaucoma is a rare disease, with onset in the first years of life. A distinction sometimes is made between glaucoma that is present at birth (true congenital glaucoma) and glaucoma that has onset in the first two to three years of life (infantile glaucoma) because the prognosis differs [<a href="#rid3">3</a>]. The later the onset, the less severe the structural anomaly and the more likely the glaucoma will respond to treatment. Primary infantile glaucoma is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Juvenile glaucoma</span></p><p class="headingAnchor" id="H1717240555"><span class="h3">Pathogenesis</span><span class="headingEndMark"> — </span>Primary glaucoma diagnosed after four to five years of age usually is referred to as juvenile glaucoma. The pathogenesis of juvenile glaucoma is similar to that of infantile glaucoma (angle dysgenesis), and the disorder sometimes is called late-onset primary infantile glaucoma [<a href="#rid4">4</a>]. The age at which symptoms first appear probably is related to the severity of angle dysgenesis [<a href="#rid5">5</a>].</p><p>A subset of patients with juvenile glaucoma have juvenile-onset open-angle glaucoma (JOAG), a form of primary open-angle glaucoma (POAG) that presents in childhood to early adulthood without ocular enlargement. JOAG is commonly inherited in an autosomal dominant fashion [<a href="#rid6">6,7</a>]. Molecular defects causing JOAG and POAG have been identified on the long arm of chromosome 1, including mutations in the myocilin gene (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F601652&amp;token=87jLzclRwWxNoI%2BQq5Gg7x%2FpkjRGu05T%2BRf4xNwRdexeeIUk%2BUmXwS5B5ss6E3Nt&amp;TOPIC_ID=6272" target="_blank">MYOC</a>, also known as trabecular meshwork-induced glucocorticoid response gene [<em>TIGR</em>]) [<a href="#rid8">8-13</a>]. There is considerable overlap between JOAG, POAG, and normal phenotypes, even with the same mutation. Within affected families, the age of onset is usually fairly consistent. (See  <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Clinical features</span><span class="headingEndMark"> — </span>Although the pathogenesis of infantile and juvenile glaucoma is similar, the presenting signs and symptoms differ. The presentation of juvenile glaucoma is insidious. Patients usually are asymptomatic, and optic nerve damage is occult. In patients with JOAG, a strong family history is often present, given its autosomal dominant inheritance pattern. (See <a class="local">'Pathogenesis'</a> above.)</p><p>In contrast to infantile glaucoma, which typically presents in the first few years of life when the cornea and sclera are more elastic, juvenile glaucoma is not associated with enlarged cornea or buphthalmos. Corneal edema, tearing, photophobia, headache, and eye pain are also uncommon since intraocular pressure (IOP) increases insidiously. IOP is always elevated, often severely. Because other symptoms are often lacking, elevated IOP may go unrecognized unless optic nerve cupping  (<a class="graphic graphic_picture graphicRef71467" href="/z/d/graphic/71467.html" rel="external">picture 1</a>) is noticed [<a href="#rid14">14</a>]. Vision loss may be the presenting symptoms. Peripheral vision is affected first, and if left untreated, central vision loss and blindness may occur.</p><p class="headingAnchor" id="H7"><span class="h3">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis is established based upon characteristic findings of nerve damage on fundus examination  (<a class="graphic graphic_picture graphicRef71467" href="/z/d/graphic/71467.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef50075" href="/z/d/graphic/50075.html" rel="external">picture 2</a>), typically in the presence of elevated IOP and visual field deficit. Often, the diagnosis is suspected because of a positive family history [<a href="#rid1">1</a>]. Once the diagnosis is made, children and adolescents with juvenile glaucoma are followed with IOP measurements in the office, optical coherence tomography, and/or serial automated visual field testing. The frequency of follow-up depends upon individual case severity.</p><p class="headingAnchor" id="H8"><span class="h3">Treatment</span><span class="headingEndMark"> — </span>As with infantile glaucoma, surgical intervention is the mainstay of therapy, and medications are used as an adjunct. Angle surgery (ie, goniotomy or trabeculotomy) is the first-line surgical intervention. Surgical treatment of pediatric primary glaucoma is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma", section on 'Surgery'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SECONDARY GLAUCOMA</span><span class="headingEndMark"> — </span>Secondary glaucoma can occur in many different conditions  (<a class="graphic graphic_table graphicRef56982" href="/z/d/graphic/56982.html" rel="external">table 1</a>). Some of the causes of secondary glaucoma have associated angle anomalies. In others, glaucoma may become an important complication, although it is not usually considered a primary manifestation of the disorder. Secondary glaucoma is usually suspected because of coexisting ocular and/or systemic disease. The diagnosis is confirmed with fundus examination, tonometry (ie, measurement of the intraocular pressure [IOP]), and visual field testing.</p><p class="headingAnchor" id="H10"><span class="h2">Angle anomalies</span><span class="headingEndMark"> — </span>Glaucoma occurs secondarily in several disorders that have associated angle anomalies  (<a class="graphic graphic_table graphicRef56982" href="/z/d/graphic/56982.html" rel="external">table 1</a>). Sturge-Weber syndrome (SWS), aniridia, and neural crest disorders are three of the most common disorders with secondary glaucoma, and they are discussed briefly below. For many of the other disorders listed in the table, detailed descriptions are provided separately. (See appropriate topic reviews.)</p><p>The pathogenesis of angle-anomaly glaucoma is similar to that of primary infantile and juvenile glaucoma. For this reason, the treatment strategies are similar. Surgical therapy is almost always necessary to control intraocular pressure (IOP) and preserve vision. Medical therapy is adjunctive. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H11"><span class="h3">Sturge-Weber syndrome</span><span class="headingEndMark"> — </span>The classic triad of SWS includes facial port wine birthmark  (<a class="graphic graphic_picture graphicRef59124 graphicRef73978" href="/z/d/graphic/59124.html" rel="external">picture 3A-B</a>), intracranial angiomata, and glaucoma  (<a class="graphic graphic_picture graphicRef74289" href="/z/d/graphic/74289.html" rel="external">picture 4</a>). Individuals with SWS can develop glaucoma even if they do not have the classic triad [<a href="#rid15">15,16</a>]. Systemic manifestations may include seizures, intellectual disability, paresis, and cerebral calcifications. SWS is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/6159.html" rel="external">"Sturge-Weber syndrome"</a>.)</p><p>SWS is a sporadic disorder, with only rare familial cases. Although the syndrome is rare, it is one of the more common causes of secondary glaucoma in children.</p><p>Glaucoma has been reported in 40 to 60 percent of patients with SWS [<a href="#rid17">17,18</a>]. Glaucoma is most often unilateral on the same side as the port wine birthmark. Patients who develop glaucoma usually have port wine birthmarks of both the upper and lower eyelids. The risk of glaucoma is highest in the first decade of life. Approximately one-half of patients with SWS have glaucoma at birth and present with enlargement of the globe and the other hallmarks of infantile glaucoma (tearing, photophobia, corneal enlargement). Occasionally, patients develop glaucoma in adulthood [<a href="#rid19">19</a>]. Thus, continued vigilance is needed, even in patients with initially normal IOP.</p><p>The pathogenesis of the glaucoma is variable, depending upon the age of onset [<a href="#rid20">20</a>]. Most cases that present early are due to a developmental angle anomaly that is indistinguishable from that in primary infantile glaucoma [<a href="#rid21">21</a>]. Other possible mechanisms for later-onset glaucoma include hypersecretion from an associated angioma of the choroid, elevated venous pressure associated with an episcleral hemangioma [<a href="#rid20">20,22</a>], or a combination of these abnormalities.</p><p>As is the case with primary pediatric glaucoma, surgery is the mainstay of treatment for glaucoma in patients with SWS [<a href="#rid23">23,24</a>]. However, some patients can be successfully managed medically [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma", section on 'Surgery'</a> and  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma", section on 'Medical therapy'</a>.)</p><p>The surgical success rate is generally lower and the complication rate higher in glaucoma associated with SWS, especially in those with an associated fundus hemangioma  (<a class="graphic graphic_picture graphicRef74289" href="/z/d/graphic/74289.html" rel="external">picture 4</a>).</p><p class="headingAnchor" id="H12"><span class="h3">Aniridia</span><span class="headingEndMark"> — </span>Aniridia is a rare congenital abnormality caused by mutations in the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F607108&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdypq1RopDrWi65RSjFSWAKu8&amp;TOPIC_ID=6272" target="_blank"><i>PAX6</i></a> gene, which is involved in the early development of the eyes, brain, and central nervous system. The majority of cases are sporadic, with occasional familial cases. The familial cases are autosomal dominant and involve deletion of chromosome 11p13, a deletion that increases the risk of Wilms tumor (also known as the WAGR syndrome [<strong>W</strong>ilms tumor, <strong>a</strong>niridia, <strong>g</strong>enitourinary anomalies, and mental <strong>r</strong>etardation]) [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">"Microdeletion syndromes (chromosomes 1 to 11)", section on '11p13 deletion syndrome (WAGR syndrome)'</a>.)</p><p>The ocular manifestations of aniridia are not limited to the iris, although it is nearly always affected. The iris may be almost completely absent, sometimes with only a small residual stump visible only on gonioscopy, or have only minor changes. Other ocular manifestations include foveal hypoplasia, nystagmus, optic nerve hypoplasia, glaucoma, and progressive corneal degenerative changes. Glaucoma often presents in infancy but can present at any time.</p><p>The pathogenesis of the glaucoma in aniridia is multifactorial. A minority of patients have an anomalous angle present from birth [<a href="#rid26">26</a>]. Others form iris adhesions within the anterior chamber angle and go on to develop chronic angle closure glaucoma. Thus, aniridic glaucoma can result from congenital or acquired structural angle anomalies. Patients with aniridia should be regularly monitored for the development of glaucoma. Evaluation should include assessment of corneal signs (eg, edema, enlargement), examination of the optic nerve, and measurement of IOP.</p><p>The treatment of aniridic glaucoma is difficult. Goniotomy appears to be a reasonable option for patients with an open angle. Some authors have suggested prophylactic goniotomy for patients with aniridia [<a href="#rid27">27</a>]; however, this is controversial [<a href="#rid28">28</a>]. Trabeculotomy or tube shunting may be best suited for patients with angle closure [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Anterior segment dysgenesis</span><span class="headingEndMark"> — </span>Anterior segment dysgenesis refers to developmental defects of the anterior segment and iris that result in a spectrum of ocular and systemic manifestations. </p><p>Anterior segment dysgenesis represents an arrest in late gestational development that may result in retained primitive endothelium, failure of the peripheral iris to migrate posteriorly, and/or failure of the corneal endothelium to fully differentiate. Individual disorders within this spectrum include [<a href="#rid30">30-32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Posterior embryotoxon or anteriorly displaced Schwalbe's line.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Axenfeld-Rieger syndrome, which includes disorders formerly known as Axenfeld anomaly, Axenfeld syndrome, Rieger anomaly, Rieger syndrome, and iridogoniodysgenesis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior keratoconus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peters anomaly, a central defect in the corneal endothelium with various degrees of adhesion of the iris and lens capsule to the central cornea, with a resultant corneal leukoma (whitish plaque).</p><p></p><p>Glaucoma occurs at some time in approximately 60 percent of patients with these disorders. It may occur during infancy or much later. The increased IOP appears to be related to developmental angle anomalies. Patients with anterior segment dysgenesis should be monitored regularly for the development of glaucoma. Evaluation should include assessment of corneal signs (eg, edema, enlargement), examination of the optic nerve, and measurement of IOP.</p><p>These disorders were formerly known as anterior chamber cleavage syndromes or mesodermal dysgenesis; however, these terms are no longer used because it is now known that neural crest cells, not mesoderm, are primarily responsible for anterior segment development and that the simple concept of anterior segment "cleavage" may not be valid.</p><p class="headingAnchor" id="H14"><span class="h2">Retinopathy of prematurity</span><span class="headingEndMark"> — </span>Retinopathy of prematurity (ROP) is a developmental vascular proliferative disorder that occurs in the incompletely vascularized retina of premature infants. It is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6263.html" rel="external">"Retinopathy of prematurity (ROP): Risk factors, classification, and screening", section on 'Introduction'</a>.)</p><p>Glaucoma is a severe, late complication of ROP. It can occur across the spectrum of visual acuity and at any time. Between one-quarter and one-third of patients with stage 5 ROP (complete retinal detachment) develop glaucoma as a complication [<a href="#rid33">33</a>]. Diminished visual acuity and/or pain (particularly in blind eyes) may suggest the diagnosis of glaucoma in patients with ROP.</p><p>The pathogenesis of glaucoma in ROP varies. Mechanisms include contraction of the retrolental membranes leading to anterior rotation of the lens-iris diaphragm and secondary angle closure [<a href="#rid34">34-37</a>], high iris convexity, anterior iris insertion, pigment clumping in the trabecular meshwork, and the appearance of a translucent matrix in the angle structures [<a href="#rid33">33</a>].</p><p>The treatment of glaucoma in ROP varies depending upon the underlying mechanism. If glaucoma is caused by forward displacement of the lens-iris diaphragm, lensectomy is the preferred procedure. Medications and/or surgery may be used in other cases. Although more common in those treated for ROP, there have been reports of secondary glaucoma in untreated patients with ROP patients as well [<a href="#rid38">38</a>]. </p><p class="headingAnchor" id="H15"><span class="h2">Aphakia (due to cataract surgery)</span><span class="headingEndMark"> — </span>Children who have undergone cataract surgery are at risk for developing secondary open-angle or angle-closure glaucoma [<a href="#rid39">39</a>]. The term "aphakic glaucoma" is used for this category since cataract surgery involves removal of the crystalline lens. Both children who have had cataract extraction without implantation of an intraocular lens (true aphakia) and those who have had cataract extraction with placement of an intraocular lens (either at time of cataract surgery or subsequently, both deemed pseudophakia) are placed in the aphakic glaucoma category. In one series, aphakic glaucoma accounted for 20 percent of cases of pediatric glaucoma presenting to a children's hospital over a 20-year period [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/z/d/html/6270.html" rel="external">"Cataract in children", section on 'Postoperative complications'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – The prevalence of glaucoma as a complication of pediatric cataract surgery has changed as surgical techniques have evolved. Current irrigation/aspiration techniques for congenital cataract surgery, coupled with mechanical anterior vitrectomy, seem to have reduced the rate of postoperative glaucoma [<a href="#rid41">41</a>]. However, the exact prevalence is not known. In one study of 137 patients who had undergone congenital cataract surgery and were followed for a mean of 9.6 years, glaucoma developed in 12 percent of the eyes [<a href="#rid42">42</a>]. In a meta-analysis using individual patient data on 470 children who underwent cataract surgery in infancy, 80 (17 percent) developed glaucoma at a median follow-up of 4.3 years [<a href="#rid43">43</a>]. The risk was highest among patients who underwent surgery at ≤4 weeks of age. Microphthalmos is an important risk factor for developing glaucoma after cataract surgery. In general, younger age at surgery and degree of other eye malformations are strongly correlated with subsequent risk of glaucoma development [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1">The implantation of an intraocular lens (pseudophakia) does not appear to decrease the incidence of glaucoma after cataract surgery [<a href="#rid44">44,45</a>]. (See  <a class="medical medical_review" href="/z/d/html/6270.html" rel="external">"Cataract in children", section on 'Optical and visual rehabilitation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong>– Several factors may contribute to the development of aphakic glaucoma [<a href="#rid46">46,47</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An underlying anterior segment defect that contributed to the development of congenital cataract</p><p class="bulletIndent2"><span class="glyph">•</span>Subclinical angle anomalies</p><p class="bulletIndent2"><span class="glyph">•</span>Predisposition from the combination of cataract and microcornea</p><p class="bulletIndent2"><span class="glyph">•</span>Early exposure to intraocular inflammation from cataract extraction</p><p></p><p class="bulletIndent1">The role of corneal thickness in these patients is uncertain. Many patients demonstrate abnormally thick corneas, which may artificially raise IOP measurements.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring</strong> – Children who have undergone cataract surgery should be monitored for the development of glaucoma with periodic tonometry and examination of the optic nerve [<a href="#rid48">48</a>]. Most patients who develop aphakic glaucoma do so within four to six years of their cataract surgery, with an average of approximately one year postsurgery [<a href="#rid49">49,50</a>]. However, glaucoma can occasionally develop at &gt;8 to 10 years after cataract surgery [<a href="#rid41">41,51</a>]. Thus, patients who have had infantile cataract surgery should be followed for life. Excessive loss of hyperopia (farsightedness), the induction of frank myopia (nearsightedness), or corneal clouding in the aphakic patient should raise immediate suspicion of glaucoma [<a href="#rid52">52,53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Aphakic glaucoma may respond to medical therapy. Thus, a trial of medical therapy usually is attempted before undertaking surgical intervention. Pharmacologic therapy consists of topical IOP-lowering agents that are commonly used in adults with glaucoma. (See  <a class="medical medical_review" href="/z/d/html/15695.html" rel="external">"Open-angle glaucoma: Treatment", section on 'Pharmacologic therapies'</a>.). </p><p></p><p class="bulletIndent1">In addition, <a class="drug drug_pediatric" data-topicid="106576" href="/z/d/drug information/106576.html" rel="external">echothiophate</a> can be used in this population since the aphakia (or pseudophakia) prevents the side effect of tonic accommodation. </p><p></p><p class="bulletIndent1">Surgery is reserved for patients who are refractory to medical therapy. The outcome of surgery for aphakic glaucoma is less favorable than that for primary congenital glaucoma [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma", section on 'Surgery'</a>.)</p><p></p><p class="headingAnchor" id="H16"><span class="h2">Intraocular inflammation</span><span class="headingEndMark"> — </span>Glaucoma can occur as a complication of inflammation or uveitis. The mechanism is similar regardless of age of onset: damage to and blockage of trabecular meshwork by inflammatory cells or scarring. The underlying cause of uveitis varies by age. Inflammatory glaucoma in children usually is a complication of juvenile idiopathic arthritis (formerly juvenile rheumatoid arthritis) or sarcoidosis or is idiopathic (often of viral etiology). (See  <a class="medical medical_review" href="/z/d/html/5581.html" rel="external">"Uveitis: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p>Control of inflammation is the mainstay of treatment. Acute trabeculitis, inflammatory obstruction, and pupillary block usually respond to corticosteroids and antiglaucoma medications. Goniotomy has been shown to be an effective procedure in children whose IOP remains elevated despite medical therapy [<a href="#rid54">54,55</a>]. Glaucoma from angle closure usually requires trabeculectomy or tube shunt surgery.</p><p class="headingAnchor" id="H17"><span class="h2">Tumors</span><span class="headingEndMark"> — </span>Glaucoma can occur as a complication of ocular tumors, particularly retinoblastoma, but occasionally other types of tumors (eg, medulloepithelioma, juvenile xanthogranuloma, histiocytosis X, leukemia). (See  <a class="medical medical_review" href="/z/d/html/6275.html" rel="external">"Retinoblastoma: Clinical presentation, evaluation, and diagnosis"</a>.) </p><p>Secondary glaucoma can result from:</p><p class="bulletIndent1"><span class="glyph">●</span>Tumor infiltration of the angle</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammation of the angle</p><p class="bulletIndent1"><span class="glyph">●</span>Secondary hemorrhage into the angle [<a href="#rid56">56</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Angle closure, produced by anterior displacement of the iris-lens diaphragm by a bulky tumor (typical in retinoblastoma)</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Trauma</span><span class="headingEndMark"> — </span>Glaucoma can occur as an acute or late complication of blunt or penetrating ocular trauma. The mechanisms for traumatic glaucoma include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hyphema, with blockage of the trabecular meshwork with red blood cells or debris </p><p class="bulletIndent1"><span class="glyph">●</span>Damage to the angle, leading to decreased outflow of aqueous (a late complication)</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammation of the trabecular meshwork</p><p class="bulletIndent1"><span class="glyph">●</span>Damage to the lens</p><p></p><p>Glaucoma associated with hyphema requires urgent referral and management because IOP can rise rapidly to high levels, causing damage to the optic nerve and blood staining of the cornea. Surgical evacuation of the blood collection may be necessary if the IOP cannot be controlled. Modest elevation of IOP usually responds to temporary medical therapy. Patients with sickle cell disease can present with significant increases in IOP with minimal hyphema. They typically do not respond well to medical management and require early anterior chamber washout. (See  <a class="medical medical_review" href="/z/d/html/95661.html" rel="external">"Traumatic hyphema: Management", section on 'Patients with intraocular hypertension'</a> and  <a class="medical medical_review" href="/z/d/html/95661.html" rel="external">"Traumatic hyphema: Management", section on 'Surgical clot evacuation'</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Steroid-induced</span><span class="headingEndMark"> — </span>Steroid-induced glaucoma is more common among adults but can occur in children. This form of glaucoma occurs most commonly in patients who use corticosteroid eye drops, although it has been observed infrequently in chronic and, to a lesser extent, acute systemic corticosteroid use [<a href="#rid57">57,58</a>]. The mechanism of steroid-induced glaucoma remains unknown. The condition usually subsides after discontinuation of steroids. (See  <a class="medical medical_review" href="/z/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids", section on 'Ophthalmologic effects'</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition </strong>– Glaucoma is a heterogeneous group of eye diseases that are characterized by a progressive optic neuropathy, manifested by cupping of the optic disc  (<a class="graphic graphic_picture graphicRef71467" href="/z/d/graphic/71467.html" rel="external">picture 1</a>) and usually, but not always, associated with increased intraocular pressure (IOP). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Open-angle versus angle-closure glaucoma</strong> – Glaucoma can occur in open-angle or angle-closure forms. Angle-closure glaucoma is characterized by narrowing or closure of the anterior chamber angle  (<a class="graphic graphic_figure graphicRef71234 graphicRef59454" href="/z/d/graphic/71234.html" rel="external">figure 1A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/6909.html" rel="external">"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/z/d/html/6903.html" rel="external">"Angle-closure glaucoma", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Primary versus secondary forms</strong> – Both open-angle and angle-closure glaucoma can be classified into primary and secondary types  (<a class="graphic graphic_table graphicRef56982" href="/z/d/graphic/56982.html" rel="external">table 1</a>). (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary glaucomas</strong> – These are conditions in which there is an isolated angle malformation (trabeculodysgenesis). Onset may be at birth, in the first few years of life, or later in life. (See <a class="local">'Primary glaucoma'</a> above.)</p><p></p><p class="bulletIndent1">Primary infantile glaucoma is a rare disease, with onset in the first years of life. It is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/6273.html" rel="external">"Primary infantile glaucoma"</a>.)</p><p></p><p class="bulletIndent1">Juvenile glaucoma refers to primary glaucoma diagnosed after four to five years of age. Patients are usually asymptomatic, and optic nerve damage is occult. The diagnosis is established based upon characteristic findings of nerve damage on fundus examination  (<a class="graphic graphic_picture graphicRef71467" href="/z/d/graphic/71467.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef50075" href="/z/d/graphic/50075.html" rel="external">picture 2</a>), typically in the presence of elevated IOP and visual field deficit. Often, the diagnosis is suspected because of a positive family history. Surgical intervention is the mainstay of therapy, and medications are used as an adjunct. (See <a class="local">'Juvenile glaucoma'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Secondary glaucoma</strong> – Secondary glaucoma can occur in many different conditions  (<a class="graphic graphic_table graphicRef56982" href="/z/d/graphic/56982.html" rel="external">table 1</a>). Causes of secondary glaucoma include (see <a class="local">'Secondary glaucoma'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Angle anomalies (eg, Sturge-Weber syndrome (SWS), aniridia, anterior segment dysgenesis) (see <a class="local">'Angle anomalies'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Retinopathy of prematurity (ROP) (see <a class="local">'Retinopathy of prematurity'</a> above and  <a class="medical medical_review" href="/z/d/html/6263.html" rel="external">"Retinopathy of prematurity (ROP): Risk factors, classification, and screening"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Aphakia (due to cataract surgery) (see <a class="local">'Aphakia (due to cataract surgery)'</a> above and  <a class="medical medical_review" href="/z/d/html/6270.html" rel="external">"Cataract in children", section on 'Postoperative complications'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Intraocular inflammation (see <a class="local">'Intraocular inflammation'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Ocular tumors (see <a class="local">'Tumors'</a> above and  <a class="medical medical_review" href="/z/d/html/6275.html" rel="external">"Retinoblastoma: Clinical presentation, evaluation, and diagnosis"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Trauma (see <a class="local">'Trauma'</a> above and  <a class="medical medical_review" href="/z/d/html/6570.html" rel="external">"Traumatic hyphema: Clinical features and diagnosis"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Exposure to glucocorticoids (see <a class="local">'Steroid-induced'</a> above and  <a class="medical medical_review" href="/z/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids", section on 'Ophthalmologic effects'</a>)</p><p></p><p class="bulletIndent1">Secondary glaucoma is usually suspected because of coexisting ocular and/or systemic disease. The diagnosis is confirmed with fundus examination, tonometry (measurement of IOP), and visual field testing. </p><p></p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kipp MA. Childhood glaucoma. Pediatr Clin North Am 2003; 50:89.</a></li><li><a class="nounderline abstract_t">Hoskins HD Jr, Shaffer RN, Hetherington J. Anatomical classification of the developmental glaucomas. Arch Ophthalmol 1984; 102:1331.</a></li><li><a class="nounderline abstract_t">Sinha G, Patil B, Sihota R, et al. Visual field loss in primary congenital glaucoma. J AAPOS 2015; 19:124.</a></li><li><a class="nounderline abstract_t">Beck AD. Diagnosis and management of pediatric glaucoma. Ophthalmol Clin North Am 2001; 14:501.</a></li><li><a class="nounderline abstract_t">Tawara A, Inomata H. Developmental immaturity of the trabecular meshwork in juvenile glaucoma. Am J Ophthalmol 1984; 98:82.</a></li><li><a class="nounderline abstract_t">Goldwyn R, Waltman SR, Becker B. Primary open-angle glaucoma in adolescents and young adults. Arch Ophthalmol 1970; 84:579.</a></li><li><a class="nounderline abstract_t">Johnson AT, Drack AV, Kwitek AE, et al. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology 1993; 100:524.</a></li><li><a class="nounderline abstract_t">Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998; 338:1022.</a></li><li><a class="nounderline abstract_t">Belmouden A, Adam MF, Dupont de Dinechin S, et al. Recombinational and physical mapping of the locus for primary open-angle glaucoma (GLC1A) on chromosome 1q23-q25. Genomics 1997; 39:348.</a></li><li><a class="nounderline abstract_t">Graff C, Urbak SF, Jerndal T, Wadelius C. Confirmation of linkage to 1q21-31 in a Danish autosomal dominant juvenile-onset glaucoma family and evidence of genetic heterogeneity. Hum Genet 1995; 96:285.</a></li><li><a class="nounderline abstract_t">Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 1993; 4:47.</a></li><li><a class="nounderline abstract_t">Wiggs JL, Del Bono EA, Schuman JS, et al. Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31. Ophthalmology 1995; 102:1782.</a></li><li><a class="nounderline abstract_t">Richards JE, Ritch R, Lichter PR, et al. Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigree. Ophthalmology 1998; 105:1698.</a></li><li><a class="nounderline abstract_t">Richards JE, Lichter PR, Boehnke M, et al. Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq. Am J Hum Genet 1994; 54:62.</a></li><li><a class="nounderline abstract_t">Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics 1985; 76:48.</a></li><li><a class="nounderline abstract_t">Khaier A, Nischal KK, Espinosa M, Manoj B. Periocular port wine stain: the great ormond street hospital experience. Ophthalmology 2011; 118:2274.</a></li><li><a class="nounderline abstract_t">Sharan S, Swamy B, Taranath DA, et al. Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome. J AAPOS 2009; 13:374.</a></li><li><a class="nounderline abstract_t">Hennedige AA, Quaba AA, Al-Nakib K. Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness. Plast Reconstr Surg 2008; 121:1173.</a></li><li><a class="nounderline abstract_t">Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995; 10:49.</a></li><li><a class="nounderline abstract_t">Phelps CD. The pathogenesis of glaucoma in Sturge-Weber syndrome. Ophthalmology 1978; 85:276.</a></li><li><a class="nounderline abstract_t">Cibis GW, Tripathi RC, Tripathi BJ. Glaucoma in Sturge-Weber syndrome. Ophthalmology 1984; 91:1061.</a></li><li><a class="nounderline abstract_t">Kranemann CF, Pavlin CJ, Trope GE. Ultrasound biomicroscopy in Sturge-Weber-associated glaucoma. Am J Ophthalmol 1998; 125:119.</a></li><li><a class="nounderline abstract_t">van Emelen C, Goethals M, Dralands L, Casteels I. Treatment of glaucoma in children with Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 2000; 37:29.</a></li><li><a class="nounderline abstract_t">Olsen KE, Huang AS, Wright MM. The efficacy of goniotomy/trabeculotomy in early-onset glaucoma associated with the Sturge-Weber syndrome. J AAPOS 1998; 2:365.</a></li><li><a class="nounderline abstract_t">Awad AH, Mullaney PB, Al-Mesfer S, Zwaan JT. Glaucoma in Sturge-Weber syndrome. J AAPOS 1999; 3:40.</a></li><li><a class="nounderline abstract_t">Margo CE. Congenital aniridia: a histopathologic study of the anterior segment in children. J Pediatr Ophthalmol Strabismus 1983; 20:192.</a></li><li><a class="nounderline abstract_t">Chen TC, Walton DS. Goniosurgery for prevention of aniridic glaucoma. Arch Ophthalmol 1999; 117:1144.</a></li><li><a class="nounderline abstract_t">Walton DS. Aniridic glaucoma: the results of gonio-surgery to prevent and treat this problem. Trans Am Ophthalmol Soc 1986; 84:59.</a></li><li><a class="nounderline abstract_t">Adachi M, Dickens CJ, Hetherington J Jr, et al. Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma. Ophthalmology 1997; 104:2121.</a></li><li><a class="nounderline abstract_t">Waring GO 3rd, Rodrigues MM, Laibson PR. Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol 1975; 20:3.</a></li><li><a class="nounderline abstract_t">Alward WL. Axenfeld-Rieger syndrome in the age of molecular genetics. Am J Ophthalmol 2000; 130:107.</a></li><li><a class="nounderline abstract_t">Shields MB. Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc 1983; 81:736.</a></li><li><a class="nounderline abstract_t">Hartnett ME, Gilbert MM, Richardson TM, et al. Anterior segment evaluation of infants with retinopathy of prematurity. Ophthalmology 1990; 97:122.</a></li><li><a class="nounderline abstract_t">COHEN J, ALFANO JE, BOSHES LD, PALMGREN C. CLINICAL EVALUATION OF SCHOOL-AGE CHILDREN WITH RETROLENTAL FIBROPLASIA. Am J Ophthalmol 1964; 57:41.</a></li><li><a class="nounderline abstract_t">Merritt JC, Kraybill EN. Retrolental fibroplasia: a five-year experience in a tertiary perinatal center. Ann Ophthalmol 1986; 18:65.</a></li><li><a class="nounderline abstract_t">Pollard ZF. Secondary angle-closure glaucoma in cicatricial retrolental fibroplasia. Am J Ophthalmol 1980; 89:651.</a></li><li><a class="nounderline abstract_t">Trigler L, Weaver RG Jr, O'Neil JW, et al. Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. J AAPOS 2005; 9:17.</a></li><li><a class="nounderline abstract_t">Chang TC, Tran KD, Cernichiaro-Espinosa LA, et al. Microcornea and Thickened Lens in Angle Closure following Nonsurgical Treatment of Retinopathy of Prematurity. J Ophthalmol 2020; 2020:7510903.</a></li><li><a class="nounderline abstract_t">Egbert JE, Wright MM, Dahlhauser KF, et al. A prospective study of ocular hypertension and glaucoma after pediatric cataract surgery. Ophthalmology 1995; 102:1098.</a></li><li><a class="nounderline abstract_t">Taylor RH, Ainsworth JR, Evans AR, Levin AV. The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS 1999; 3:308.</a></li><li><a class="nounderline abstract_t">Simon JW, Mehta N, Simmons ST, et al. Glaucoma after pediatric lensectomy/vitrectomy. Ophthalmology 1991; 98:670.</a></li><li><a class="nounderline abstract_t">Magnusson G, Abrahamsson M, Sjöstrand J. Glaucoma following congenital cataract surgery: an 18-year longitudinal follow-up. Acta Ophthalmol Scand 2000; 78:65.</a></li><li><a class="nounderline abstract_t">Mataftsi A, Haidich AB, Kokkali S, et al. Postoperative glaucoma following infantile cataract surgery: an individual patient data meta-analysis. JAMA Ophthalmol 2014; 132:1059.</a></li><li><a class="nounderline abstract_t">Trivedi RH, Wilson ME Jr, Golub RL. Incidence and risk factors for glaucoma after pediatric cataract surgery with and without intraocular lens implantation. J AAPOS 2006; 10:117.</a></li><li><a class="nounderline abstract_t">Solebo AL, Cumberland P, Rahi JS, British Isles Congenital Cataract Interest Group. 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study. Lancet Child Adolesc Health 2018; 2:863.</a></li><li><a class="nounderline abstract_t">Phelps CD, Arafat NI. Open-angle glaucoma following surgery for congenital cataracts. Arch Ophthalmol 1977; 95:1985.</a></li><li><a class="nounderline abstract_t">Wallace DK, Plager DA. Corneal diameter in childhood aphakic glaucoma. J Pediatr Ophthalmol Strabismus 1996; 33:230.</a></li><li><a class="nounderline abstract_t">Keech RV, Tongue AC, Scott WE. Complications after surgery for congenital and infantile cataracts. Am J Ophthalmol 1989; 108:136.</a></li><li><a class="nounderline abstract_t">Walton DS. Pediatric aphakic glaucoma: a study of 65 patients. Trans Am Ophthalmol Soc 1995; 93:403.</a></li><li><a class="nounderline abstract_t">Johnson CP, Keech RV. Prevalence of glaucoma after surgery for PHPV and infantile cataracts. J Pediatr Ophthalmol Strabismus 1996; 33:14.</a></li><li><a class="nounderline abstract_t">Belitsky Y, Magnusson G, Nyström A, et al. Late-onset glaucoma following congenital cataract surgery: Occurrence, visual acuity and risk factors: A 37-year longitudinal follow-up. Acta Ophthalmol 2023; 101:170.</a></li><li><a class="nounderline abstract_t">Egbert JE, Kushner BJ. Excessive loss of hyperopia. A presenting sign of juvenile aphakic glaucoma. Arch Ophthalmol 1990; 108:1257.</a></li><li><a class="nounderline abstract_t">Wang VM, Demer JL, Rosenbaum A, Weissman BA. Diagnosing glaucoma in pediatric aphakia. Optometry 2002; 73:704.</a></li><li><a class="nounderline abstract_t">Ho CL, Wong EY, Walton DS. Goniosurgery for glaucoma complicating chronic childhood uveitis. Arch Ophthalmol 2004; 122:838.</a></li><li><a class="nounderline abstract_t">Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol 2013; 155:134.</a></li><li><a class="nounderline abstract_t">Kwitko ML. Secondary glaucoma in infancy and childhood. A review. Can J Ophthalmol 1969; 4:231.</a></li><li><a class="nounderline abstract_t">Long WF. A case of elevated intraocular pressure associated with systemic steroid therapy. Am J Optom Physiol Opt 1977; 54:248.</a></li><li><a class="nounderline abstract_t">François J. Corticosteroid glaucoma. Ophthalmologica 1984; 188:76.</a></li></ol></div><div id="topicVersionRevision">Topic 6272 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12713106" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Childhood glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6477252" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Anatomical classification of the developmental glaucomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25892039" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Visual field loss in primary congenital glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11705150" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diagnosis and management of pediatric glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6742083" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Developmental immaturity of the trabecular meshwork in juvenile glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5478882" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Primary open-angle glaucoma in adolescents and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8479711" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9535666" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9119372" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Recombinational and physical mapping of the locus for primary open-angle glaucoma (GLC1A) on chromosome 1q23-q25.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7649543" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Confirmation of linkage to 1q21-31 in a Danish autosomal dominant juvenile-onset glaucoma family and evidence of genetic heterogeneity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8513321" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9098278" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9754180" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigree.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8279471" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4011357" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Facial port-wine stains and Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21783256" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Periocular port wine stain: the great ormond street hospital experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19683189" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18349634" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7769179" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/662281" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The pathogenesis of glaucoma in Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6493715" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Glaucoma in Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9437332" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ultrasound biomicroscopy in Sturge-Weber-associated glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10714693" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Treatment of glaucoma in children with Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10532726" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The efficacy of goniotomy/trabeculotomy in early-onset glaucoma associated with the Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10071900" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Glaucoma in Sturge-Weber syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6631651" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Congenital aniridia: a histopathologic study of the anterior segment in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10496385" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Goniosurgery for prevention of aniridic glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3590479" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Aniridic glaucoma: the results of gonio-surgery to prevent and treat this problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9400774" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/808872" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Anterior chamber cleavage syndrome. A stepladder classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11004268" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Axenfeld-Rieger syndrome in the age of molecular genetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6676983" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Axenfeld-Rieger syndrome: a theory of mechanism and distinctions from the iridocorneal endothelial syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2314833" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Anterior segment evaluation of infants with retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14106901" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : CLINICAL EVALUATION OF SCHOOL-AGE CHILDREN WITH RETROLENTAL FIBROPLASIA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3754104" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Retrolental fibroplasia: a five-year experience in a tertiary perinatal center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6892865" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Secondary angle-closure glaucoma in cicatricial retrolental fibroplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15729275" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32454993" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Microcornea and Thickened Lens in Angle Closure following Nonsurgical Treatment of Retinopathy of Prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9121758" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A prospective study of ocular hypertension and glaucoma after pediatric cataract surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10532577" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The epidemiology of pediatric glaucoma: the Toronto experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2062500" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Glaucoma after pediatric lensectomy/vitrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10726793" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Glaucoma following congenital cataract surgery: an 18-year longitudinal follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24921712" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Postoperative glaucoma following infantile cataract surgery: an individual patient data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16678745" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Incidence and risk factors for glaucoma after pediatric cataract surgery with and without intraocular lens implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30389448" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/921576" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Open-angle glaucoma following surgery for congenital cataracts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8880615" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Corneal diameter in childhood aphakic glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2667370" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Complications after surgery for congenital and infantile cataracts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8719689" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Pediatric aphakic glaucoma: a study of 65 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8965218" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prevalence of glaucoma after surgery for PHPV and infantile cataracts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36036699" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Late-onset glaucoma following congenital cataract surgery: Occurrence, visual acuity and risk factors: A 37-year longitudinal follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2400345" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Excessive loss of hyperopia. A presenting sign of juvenile aphakic glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12516800" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Diagnosing glaucoma in pediatric aphakia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15197058" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Goniosurgery for glaucoma complicating chronic childhood uveitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23036573" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Surgical outcomes in childhood uveitic glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4980015" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Secondary glaucoma in infancy and childhood. A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/143890" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A case of elevated intraocular pressure associated with systemic steroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6231514" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Corticosteroid glaucoma.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
